Companies / CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc.
CBAYCIK 1042074
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 11, 2023 | Shah Sujal Executive | Sell Open-market sale | Common Stock | $1.28M | -64K -27.19% | 171,301 | medium |
| Apr 17, 2023 | Kim Dennis D Executive | Sell Open-market sale | Common Stock | $1.07M | -112K -84.87% | 20,000 | medium |
| Oct 9, 2023 | Shah Sujal Executive | Sell Open-market sale | Common Stock | $921.3K | -65K -27.46% | 171,301 | medium |
| Nov 13, 2023 | Shah Sujal Executive | Sell Open-market sale | Common Stock | $699.3K | -44K -20.44% | 171,301 | medium |
| Apr 17, 2023 | Kim Dennis D Executive | Exercise Option exercise | Common Stock | $490.4K | +112K +561.10% | 132,219 | low |
| Sep 15, 2023 | Quinlan Paul T Executive | Sell Open-market sale | Common Stock | $404.9K | -24K -100.00% | 0 | medium |
| Sep 15, 2023 | Quinlan Paul T Executive | Sell Open-market sale | Common Stock | $404.9K | -24K -100.00% | 0 | medium |
| Sep 18, 2023 | McWherter Charles Executive | Sell Open-market sale | Common Stock | $352.7K | -22K -59.18% | 15,000 | medium |